Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Assertio Therapeutics Inc (ASRT)

Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 80,774
  • Shares Outstanding, K 95,478
  • Annual Sales, $ 152,070 K
  • Annual Income, $ -331,940 K
  • EBIT $ 21 M
  • EBITDA $ 50 M
  • 60-Month Beta 0.82
  • Price/Sales 0.56
  • Price/Cash Flow 1.22
  • Price/Book 0.65
  • Price/Earnings ttm 22.15
  • Earnings Per Share ttm 0.04
  • Most Recent Earnings $-0.03 on 11/11/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 118.12% ( -9.59%)
  • Historical Volatility 68.55%
  • IV Percentile 64%
  • IV Rank 18.55%
  • IV High 594.54% on 09/13/24
  • IV Low 9.59% on 10/17/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 47
  • Volume Avg (30-Day) 349
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 38,164
  • Open Int (30-Day) 41,222

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.04
  • Number of Estimates 2
  • High Estimate -0.03
  • Low Estimate -0.04
  • Prior Year 0.08
  • Growth Rate Est. (year over year) -150.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8100 +8.16%
on 12/20/24
1.0791 -18.81%
on 12/03/24
-0.0647 (-6.88%)
since 11/22/24
3-Month
0.7800 +12.32%
on 11/15/24
1.2480 -29.80%
on 09/27/24
-0.2939 (-25.12%)
since 09/24/24
52-Week
0.7324 +19.62%
on 04/25/24
1.7980 -51.27%
on 07/18/24
-0.2239 (-20.35%)
since 12/22/23

Most Recent Stories

More News
Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors

ASRT : 0.8761 (+3.56%)
Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study

ASRT : 0.8761 (+3.56%)
Assertio Holdings Appoints Paul Schwichtenberg as Chief Transformation Officer and Mary Pietryga as Chief Commercial Officer

Assertio Holdings creates a Transformation Office, appointing Paul Schwichtenberg as Chief Transformation Officer, and Mary Pietryga as Chief Commercial Officer.Quiver AI SummaryAssertio Holdings, Inc....

ASRT : 0.8761 (+3.56%)
Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO

ASRT : 0.8761 (+3.56%)
New Strong Buy Stocks for November 29th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Makita Corporation MKTAY: This tools and equipment manufacturing company has seen the Zacks Consensus Estimate for its current year...

CHH : 140.71 (+0.71%)
DRS : 33.02 (+0.61%)
ASRT : 0.8761 (+3.56%)
MKTAY : 30.2500 (-0.09%)
BRKL : 11.96 (+0.08%)
Assertio: Q3 Earnings Snapshot

Assertio: Q3 Earnings Snapshot

ASRT : 0.8761 (+3.56%)
Assertio Reports Third Quarter 2024 Financial Results

ASRT : 0.8761 (+3.56%)
Assertio Provides Response to Letter from Short-seller

ASRT : 0.8761 (+3.56%)
Assertio Holdings, Inc. to Report Third Quarter 2024 Financial Results on November 11, 2024

ASRT : 0.8761 (+3.56%)
Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024

ASRT : 0.8761 (+3.56%)

Business Summary

Assertio Holdings Inc. is a specialty pharmaceutical company. Its portfolio consists of branded prescription neurology, inflammation and pain medications. The company's business development includes acquisitions, licensing and mergers. Assertio Holdings Inc., formerly known as Assertio Therapeutics Inc.,...

See More

Key Turning Points

3rd Resistance Point 0.9456
2nd Resistance Point 0.9176
1st Resistance Point 0.8969
Last Price 0.8761
1st Support Level 0.8482
2nd Support Level 0.8202
3rd Support Level 0.7995

See More

52-Week High 1.7980
Fibonacci 61.8% 1.3909
Fibonacci 50% 1.2652
Fibonacci 38.2% 1.1395
Last Price 0.8761
52-Week Low 0.7324

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar